Andersen-Tawil syndrome primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:
* Sibs of a proband: The risk to the sibs of the proband depends on the genetic status of the proband's parents.  If a parent of the proband is affected and/or has the KCNJ2 mutation identified in the proband, the risk to the sibs of inheriting the mutation is 50%.  When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.  If a disease-causing mutation cannot be detected in the DNA extracted from the leukocytes of either parent, two possible explanations are germline mosaicism in a parent or a de novo mutation in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.
* Sibs of a proband: The risk to the sibs of the proband depends on the genetic status of the proband's parents.  If a parent of the proband is affected and/or has the KCNJ2 mutation identified in the proband, the risk to the sibs of inheriting the mutation is 50%.  When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.  If a disease-causing mutation cannot be detected in the DNA extracted from the leukocytes of either parent, two possible explanations are germline mosaicism in a parent or a de novo mutation in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.
* Offspring of a proband: Each child of an individual with ATS has a 50% chance of inheriting the mutation.
* Offspring of a proband: Each child of an individual with ATS has a 50% chance of inheriting the mutation.
* Other family members of a proband: The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.
* Other family members of a proband: The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.



Revision as of 21:54, 24 February 2013

Andersen-Tawil syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Andersen-Tawil syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Andersen-Tawil syndrome primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Andersen-Tawil syndrome primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Andersen-Tawil syndrome primary prevention

CDC on Andersen-Tawil syndrome primary prevention

Andersen-Tawil syndrome primary prevention in the news

Blogs on Andersen-Tawil syndrome primary prevention

Directions to Hospitals Treating Andersen-Tawil syndrome

Risk calculators and risk factors for Andersen-Tawil syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Primary Prevention

Genetic Counselling

ATS is inherited in an autosomal dominant manner. At least 50% of individuals diagnosed with ATS have anaffected parent. Up to 50% of cases are caused by de novo mutations. Each child of an individual with ATS has a 50% chance of inheriting the disorder. Prenatal diagnosis for pregnancies at increased risk is possible if the disease-causing mutation has been identified in an affected family member.

  • Parents of a proband: At least 50% of individuals diagnosed with ATS have an affected parent. A proband with ATS may have the disorder as the result of a de novo gene mutation. The proportion of cases caused by de novo mutations may be as high as 50%. Recommendations for the evaluation of parents of a proband with an apparent de novo mutation include a detailed neurologic and cardiologic evaluation, 12-lead ECG, 24-hour Holter monitoring, and molecular genetic testing for the KCNJ2 mutation identified in the proband.
  • Sibs of a proband: The risk to the sibs of the proband depends on the genetic status of the proband's parents. If a parent of the proband is affected and/or has the KCNJ2 mutation identified in the proband, the risk to the sibs of inheriting the mutation is 50%. When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low. If a disease-causing mutation cannot be detected in the DNA extracted from the leukocytes of either parent, two possible explanations are germline mosaicism in a parent or a de novo mutation in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.
  • Offspring of a proband: Each child of an individual with ATS has a 50% chance of inheriting the mutation.
  • Other family members of a proband: The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.

References


Template:WikiDoc Sources